Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03465506

Ligand	Ligand name	Chain	PDB	Tanimoto
DGH	(2R)-AMINO(4-HYDROXYPHENYL)ACETIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1W7Q	0.72
DGH	(2R)-AMINO(4-HYDROXYPHENYL)ACETIC ACID	A,B,C,D,E,F,G,H	1W7R	0.72
BP7	1,1'-BIPHENYL-3,4-DIOL	A	2EI0	0.73
AHT	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	I,T	1TMB	0.71
MBD	3-METHYLCATECHOL	A	1KNF	0.74
DAH	3,4-DIHYDROXYPHENYLALANINE	A,B	1RNR	0.74
DAH	3,4-DIHYDROXYPHENYLALANINE	A	6PAH	0.74
DAH	3,4-DIHYDROXYPHENYLALANINE	A,B	1IVV	0.74
AEH	4-(2-aminoethyl)-2-ethylphenol	A	3BUG	0.73
BPY	BIPHENYL-2,3-DIOL	A	1KMY	0.73
BPY	BIPHENYL-2,3-DIOL	B	1KW8	0.73
BPY	BIPHENYL-2,3-DIOL	A	2EI3	0.73
BPY	BIPHENYL-2,3-DIOL	A	1EIR	0.73
BPY	BIPHENYL-2,3-DIOL	B	1KW6	0.73
BPY	BIPHENYL-2,3-DIOL	B	1KWC	0.73
BPY	BIPHENYL-2,3-DIOL	B	1KW9	0.73
4CR	(1R)-4-({[ETHYL(METHYL)AMINO]CARBONYL}OXY)-N-METHYL-N-[(1E)-PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM	A,B	2C65	0.74
SDT	3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione	A,B	2ZI8	0.7
MTY	META-TYROSINE	A	2TOH	0.7
MTY	META-TYROSINE	A,B	1BIQ	0.7
MTY	META-TYROSINE	A	1Q7O	0.7
ALE	L-EPINEPHRINE	A	3PAH	0.77
ALE	L-EPINEPHRINE	A	2HKK	0.77
AEF	4-(2-aminoethyl)phenol	A	3BRA	0.71
GHP	4-HYDROXYPHENYLGLYCINE	A	1DSR	0.72
MA0	(1R)-6-HYDROXY-N-METHYL-N-[(1Z)-PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM	A,B	2C64	0.86
AEG	4-[(2R)-2-aminopropyl]phenol	A	3BUF	0.75
D4P	(2S)-AMINO(4-HYDROXYPHENYL)ACETIC ACID	A	1DSR	0.72
D4P	(2S)-AMINO(4-HYDROXYPHENYL)ACETIC ACID	A,B,C,D,E,F,G,H	1W7R	0.72
D4P	(2S)-AMINO(4-HYDROXYPHENYL)ACETIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1W7Q	0.72
REN	(S)-reticuline	A	3FWA	0.79
REN	(S)-reticuline	A	3D2D	0.79
3QC	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	A,B	2FME	0.72
247	(3R)-3-amino-2,2-difluoro-3-(4-hydroxyphenyl)propanoic acid	A,B	2QVE	0.7
LNR	L-NOREPINEPHRINE	A,B	2QEO	0.75
LNR	L-NOREPINEPHRINE	A	3DYE	0.75
LNR	L-NOREPINEPHRINE	A	4PAH	0.75
AED	4-(2-aminoethyl)-2-cyclohexylphenol	A	3BUH	0.7
Y13	(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE	A	2EW6	0.71
2MP	3,4-DIMETHYLPHENOL	A	1L5O	0.71
D1N	NAPHTHALENE-1,2-DIOL	A	2EI1	0.73
GNT	(-)-GALANTHAMINE	A	1DX6	0.71
GNT	(-)-GALANTHAMINE	A	1QTI	0.71
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.71
GNT	(-)-GALANTHAMINE	A,B	1W76	0.71
GNT	(-)-GALANTHAMINE	A	1W6R	0.71
TY3	3-HYDROXY-L-TYROSINE	A,B	2VH3	0.74
ECS	2,3,17BETA-TRIHYDROXY-1,3,5(10)-ESTRATRIENE	A,B,C,D	2BW7	0.7
LDP	L-DOPAMINE	A,B	2A3R	0.8
LDP	L-DOPAMINE	A	5PAH	0.8
LDP	L-DOPAMINE	A,B	2QMZ	0.8
LDP	L-DOPAMINE	A,B	2VQ5	0.8
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.78
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQR	0.86
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQS	0.86
MCT	4-METHYLCATECHOL	A	1L4G	0.73
MCT	4-METHYLCATECHOL	A	2EHZ	0.73
MCT	4-METHYLCATECHOL	A,B	1DMH	0.73
RHP	(3R)-3-(PROP-2-YNYLAMINO)INDAN-5-OL	A,B	1S3E	0.83
RM2	4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	A,B	2C66	0.84
BM4	3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl-3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan-3-yl]phenol	X	2W6C	0.72